3-Bromo-4-fluoro-1-methyl-1H-pyrazole

Catalog No. :
ACQXHD560
CAS No. :
2090743-53-4
Molecular Formula :
C4H4BrFN2
Molecular Weight :
178.99

IUPAC Name:3-bromo-4-fluoro-1-methyl-1H-pyrazole

3-Bromo-4-fluoro-1-methyl-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$95.00Login to see priceIn stockInquiry
100mg97%$177.00Login to see priceIn stockInquiry
250mg97%$424.00Login to see priceIn stockInquiry
1g97%$1321.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-4-fluoro-1-methyl-1H-pyrazole
IUPAC Name3-bromo-4-fluoro-1-methyl-1H-pyrazole
MDL No.MFCD31537542
Molecular FormulaC4H4BrFN2
Molecular Weight178.99
SMILESCN1N=C(Br)C(F)=C1
InChI KeyDQHYWXJVTUZXTM-UHFFFAOYSA-N
Synonym3-Bromo-4-fluoro-1-methyl-1H-pyrazole | 2090743-53-4 | 3-Bromo-4-fluoro-1-methylpyrazole | MFCD31537542 | SCHEMBL20497526 | 3-Bromo-4-fluoro-1-methylpyrazol | AS-79423 | SY047539 | CS-0161057 | P20893
CAS No.2090743-53-4
PubChem CID131506344

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQXHD560 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIWSO593 route compound structure diagram
    ACIWSO593151049-87-5 In Stock
  2. Then
  3. ACQXHD560 route product structure diagram
    ACQXHD5602090743-53-4 In Stock
Inquiry

2. ACQXHD560 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRQLX780 route compound structure diagram
    ACRQLX7801621526-49-5 In Stock
  4. Then
  5. ACQXHD560 route product structure diagram
    ACQXHD5602090743-53-4 In Stock
Inquiry

Comments (0)